Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury

Respir Res. 2005 Apr 8;6(1):31. doi: 10.1186/1465-9921-6-31.

Abstract

Background: Cellular responses to aging and oxidative stress are regulated by type 1 insulin-like growth factor receptor (IGF-1R). Oxidant injury, which is implicated in the pathophysiology of a number of respiratory diseases, acutely upregulates IGF-1R expression in the lung. This led us to suspect that reduction of IGF-1R levels in lung tissue could prevent deleterious effects of oxygen exposure.

Methods: Since IGF-1R null mutant mice die at birth from respiratory failure, we generated compound heterozygous mice harboring a hypomorphic (Igf-1rneo) and a knockout (Igf-1r-) receptor allele. These IGF-1Rneo/- mice, strongly deficient in IGF-1R, were subjected to hyperoxia and analyzed for survival time, ventilatory control, pulmonary histopathology, morphometry, lung edema and vascular permeability.

Results: Strikingly, after 72 h of exposure to 90% O2, IGF-1Rneo/- mice had a significantly better survival rate during recovery than IGF-1R+/+ mice (77% versus 53%, P < 0.05). The pulmonary injury was consistently, and significantly, milder in IGF-1Rneo/- mice which developed conspicuously less edema and vascular extravasation than controls. Also, hyperoxia-induced abnormal pattern of breathing which precipitated respiratory failure was elicited less frequently in the IGF-1Rneo/- mice.

Conclusion: Together, these data demonstrate that a decrease in IGF-1R signaling in mice protects against oxidant-induced lung injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytoprotection
  • Female
  • Hyperoxia / chemically induced
  • Hyperoxia / pathology*
  • Hyperoxia / physiopathology*
  • Lung / drug effects
  • Lung / pathology*
  • Lung / physiopathology*
  • Male
  • Mice
  • Organ Size / drug effects
  • Oxygen
  • Pulmonary Edema / chemically induced
  • Pulmonary Edema / pathology*
  • Pulmonary Edema / physiopathology*
  • Pulmonary Ventilation / drug effects
  • Receptor, IGF Type 1 / deficiency*

Substances

  • Receptor, IGF Type 1
  • Oxygen